A recent randomized crossover trial uncovered a potential breakthrough for patients with advanced non-small cell lung cancer (NSCLC). The study suggests that opting for a fuller breakfast, as opposed to a low-fat breakfast, may significantly increase the concentration of a key treatment, alectinib, in the blood. This promising finding may potentially translate into improved survival…